Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 9,251 |
|
|||||
| News | - | ||||||
| Day High | 419.50 | Low High |
|||||
| Day Low | 419.00 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Vertex Pharmaceuticals Inc | VRTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.63 | 0.15% | 419.45 | 09:30:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 419.00 | 419.00 | 419.50 | 418.82 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 119 | 9,251 | $ 419.00 | $ 3,876,169 | - | 320.01 - 448.40 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 09:30:05 | 1 | $ 419.00 | USD |
Vertex Pharmaceuticals (VRTX) Options Flow Summary
Vertex Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 108.18B | 258.31M | - | 9.92B | 3.57B | 13.82 | 30.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Vertex Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VRTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 402.95 | 425.65 | 394.0323 | 407.68 | 1,368,382 | 16.50 | 4.09% |
| 1 Month | 404.30 | 425.65 | 391.01 | 400.51 | 1,130,771 | 15.15 | 3.75% |
| 3 Months | 419.16 | 437.00 | 391.01 | 410.48 | 1,034,476 | 0.29 | 0.07% |
| 6 Months | 377.33 | 448.40 | 341.90 | 403.82 | 1,324,763 | 42.12 | 11.16% |
| 1 Year | 343.29 | 448.40 | 320.01 | 378.91 | 1,231,020 | 76.16 | 22.19% |
| 3 Years | 215.63 | 448.40 | 176.36 | 283.24 | 1,507,314 | 203.82 | 94.52% |
| 5 Years | 167.40 | 448.40 | 164.07 | 259.59 | 1,542,986 | 252.05 | 150.57% |
Vertex Pharmaceuticals Description
| Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes. |
